175081535_eylqkynhkfkbd3ib5uwahrih

.
Name : Ms. RADHIKA GARG

Lab No. : 175081535 Age : 24 Years
Ref By : Dr. PRATIBHA GARG Gender : Female
Collected : 13/9/2023 9:32:00AM Reported : 15/9/2023 11:12:59AM
A/c Status : P Report Status : Final
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector 18, National Reference laboratory, Block E,
ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085
Test Report
Test Name Results Units Bio. Ref. Interval
ANTENATAL PANEL 1
SUGAR CHOICE
(Hexokinase)
Glucose, Fasting 79.00 mg/dL 70.00 - 100.00
*175081535*
Page 1 of 18
.

Lab No. : 175081535 Age : 24 Years
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085
Test Report
COMPLETE BLOOD COUNT;CBC
Hemoglobin 12.30 g/dL 12.00 - 15.00

(Photometry)
Packed Cell Volume (PCV) 37.20 % 36.00 - 46.00
(Calculated)
RBC Count 4.31 mill/mm3 3.80 - 4.80
(Electrical Impedence)
MCV 86.20 fL 83.00 - 101.00
MCH 28.60 pg 27.00 - 32.00
(Calculated)
MCHC 33.20 g/dL 31.50 - 34.50
(Calculated)
Red Cell Distribution Width (RDW) 14.90 % 11.60 - 14.00
Total Leukocyte Count (TLC) 7.60 thou/mm3 4.00 - 10.00
Differential Leucocyte Count (DLC)
(VCS Technology)
Segmented Neutrophils 73.10 % 40.00 - 80.00
Lymphocytes 20.00 % 20.00 - 40.00
Monocytes 5.90 % 2.00 - 10.00
Eosinophils 0.50 % 1.00 - 6.00
Basophils 0.50 % <2.00
Absolute Leucocyte Count
(Calculated)
Neutrophils 5.56 thou/mm3 2.00 - 7.00
Lymphocytes 1.52 thou/mm3 1.00 - 3.00
Monocytes 0.45 thou/mm3 0.20 - 1.00
Eosinophils 0.04 thou/mm3 0.02 - 0.50
Basophils 0.04 thou/mm3 0.02 - 0.10
Platelet Count 256 thou/mm3 150.00 - 410.00
(Electrical impedence)
Mean Platelet Volume 8.8 fL 6.5 - 12.0
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
*175081535* Page 2 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood
*175081535* Page 3 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report

HEMOGLOBIN HPLC/ELECTROPHORESIS
(HPLC)
Hb F <1.00 % <1.50
Peak 2 4.10 % <9.60
Hb Adult 86.60 % 83.24 - 90.79
Hb A2 2.70 % 1.50 - 3.50
Others (Non Specific) 6.20 % <10.00
Hemoglobin 12.30 g/dL 12.00 - 15.00
RBC Count 4.31 mill/mm3 3.80 - 4.80
Packed Cell Volume (PCV) 37.20 % 36.00 - 46.00
MCV 86.20 fL 83.00 - 101.00
MCH 28.60 pg 27.00 - 32.00
RDW 14.90 % 11.60 - 14.00
*175081535*
Page 4 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report
Suggestive Interpretation
Normal Hb chromatographic pattern
*175081535*
Page 5 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report
HIV 1 & 2 ANTIBODIES SCREENING TEST, SERUM
-------------------------------
| Final Result : Negative |
-------------------------------
HIV 1 / 2 & P 24 COMBO TEST

(CMIA)
Index Value 0.06 Index <1.00
Result Negative
Interpretation
--------------------------------------------------------
| RESULT (INDEX) | REMARKS |
|------------------------|-------------------------------|
| >= 1.00 | Positive |
|------------------------|-------------------------------|
| < 1.00 | Negative |
--------------------------------------------------------
Note
1. Positive test result indicates antibody detected against HIV-1/2.
2. Negative test result indicates antibody is not detected against HIV- 1/2.
3. Indeterminate test result indicates antibody to HIV-1/2 have been detected in the sample by two of three
methods.
4. Results are reported as per the Strategy 3 of National guidelines of HIV testing by NACO, July 2015.
5. False positive results may be observed in Autoimmune diseases, Alcoholic hepatitis, Primary biliary
cirrhosis, Leprosy, Multiple pregnancies, Rheumatoid factor, and due to presence of heterophile
antibodies.
6. False negative results may occur during the window period and during the end stage of the disease.
Recommendations
1. Post-test counseling available between 9 am to 5 pm at LPL laboratories.
*175081535*
Page 6 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report

URINE EXAMINATION, ROUTINE; URINE, R/E
(Automated Strip Test, Microscopy)
Physical
Colour Light Yellow Pale yellow
Specific Gravity <=1.005 1.001 - 1.030
pH 8.5 5.0 - 8.0
Chemical
Proteins Negative Negative
Glucose Negative Negative
Ketones Negative Negative
Bilirubin Negative Negative
Urobilinogen Negative Negative
Leucocyte Esterase Negative Negative
Nitrite Negative Negative
Microscopy
R.B.C. Negative 0.0 - 2.0 RBC/hpf
Pus Cells Negative 0-5 WBC / hpf
Epithelial Cells 0-1 Epi Cells/hpf 0.0 - 5.0 Epi

cells/hpf
Casts None seen None seen/Lpf
Crystals None seen None seen
Others None seen None seen
*175081535*
Page 7 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report
RPR, SERUM Non Reactive

(Charcoal flocculation)
Interpretation
------------------------------------------------------------
| RESULT | REMARKS |
|--------------|---------------------------------------------|
| Reactive | Indicates presence of IgM & IgG antibodies |
| | against non-treponemal antigens |
|--------------|---------------------------------------------|
| Non-Reactive | Indicates absence of IgM & IgG antibodies |
| | against non-treponemal antigens |
------------------------------------------------------------
Note
1. Titers of ≥1: 8 and rising titres are significant.
2. Titers are reported only in reactive cases.
3. Positive result indicates ongoing or recent infection and the diagnosis should be confirmed by specific
Treponemal tests such as TPHA & FTA- AbS.
4. The reactivity will vary with Primary (60-86%), Secondary (99%) and Tertiary (98%) stage of Syphilis.
5. False positive results may be observed in patients of Malaria, Hepatitis, Mumps, Leprosy, Infectious
Mononucleosis, Rheumatoid Arthritis and Collagen disease.
6. False negative reaction may be due to processing of sample collected early in the course of disease,
immunosuppression and due to prozone effect.
7. Test conducted on serum.
Uses
· To screen for presence of Syphilis infection.
· To monitor the progression of disease.
· To asses the response to therapy (decreasing titres) in patients being treated for Syphilis.
HEPATITIS B SURFACE ANTIGEN;HBsAg, SERUM Non Reactive Non Reactive

(CMIA)
*Specific Antibody Neutralization Assay is performed on all Reactive results.

Interpretation
-------------------------------------------------------------------
| RESULT | REMARKS |
|--------------|----------------------------------------------------|
| Reactive | Indicates presence of Hepatitis B Surface Antigen. |
|--------------|----------------------------------------------------|
| Non-Reactive | Indicates absence of Hepatitis B Surface Antigen. |
-------------------------------------------------------------------
*175081535* Page 8 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report
Note
1. Reactive test result indicates presence of Hepatitis B Surface Antigen. It cannot differentiate between
the stages of Hepatitis B viral infection.
2. Non-Reactive test result indicates absence of Hepatitis B Surface Antigen.
3. False positive results may be observed in patients receiving mouse monoclonal antibodies, on
heparin therapy, on biotin supplements for diagnosis or therapy, in pregnancy, presence of
heterophilic antibodies in serum or after HBV vaccination for transient period of time.
4. False negative reaction may be due to processing of sample collected early in the course of disease
or presence of mutant forms of HBsAg .
5. For monitoring HBsAg levels, Quantitative HBsAg assay is recommended.
*175081535* Page 9 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report
BLOOD GROUP, ABO & RH TYPING

(Erythrocyte Magnetized Technology)
ABO Group O
Rh Factor Positive
Note: 1. Both forward and reverse grouping performed

2. Test conducted on EDTA whole blood
T4 FREE & TSH ULTRASENSITIVE

(CLIA)
Free Thyroxine (T4, Free) 1.02 ng/dL 0.89 - 1.76
TSH, Ultrasensitive 1.730 µIU/mL 0.550 - 4.780
Reference Ranges for pregnancy
-----------------------------------------------------
| PREGNANCY |REFERENCE RANGE | REFERENCE |
| |for TSH in uIU/mL | RANGE for FT4 |
| |(As per American | in ng/dL |
| |Thyroid Association)| |
|-------------|--------------------|------------------|
|1st Trimester| 0.100 - 2.500 | 0.70 -2.00 |
|-------------|--------------------|------------------|
|2st Trimester| 0.200 - 3.000 | 0.50 -1.60 |
|-------------|--------------------|------------------|
|3st Trimester| 0.300 - 3.000 | 0.50 -1.60 |
-----------------------------------------------------
Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm. The variation is of the order of 50%. hence time of the day has influence
on the measured serum TSH concentrations.
2. TSH Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals
Clinical Use
*175081535*
Page 10 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report

· Primary Hypothyroidism
· Hyperthyroidism
· Hypothalamic - Pituitary hypothyroidism
· Inappropriate TSH secretion
· Nonthyroidal illness
· Autoimmune thyroid disease
· Pregnancy associated thyroid disorders
· Thyroid dysfunction in infancy and early childhood.
*175081535*
Page 11 of 18
.

Lab No. : 175081535 Age : 24 Years
National Reference laboratory, Block E, National Reference laboratory, Block E,
Sector 18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085
Test Report

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)
HbA1c 5.7 % 4.00 - 5.60
Estimated average glucose (eAG) 117 mg/dL
Interpretation
HbA1c result is suggestive of at risk for Diabetes (Prediabetes)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines
------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------
Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.
---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------
*175081535* Page 12 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report
ERYTHROCYTE SEDIMENTATION RATE (ESR) 15 mm/hr 0.00 - 20.00

(Capillary photometry)
Note
1. C-Reactive Protein (CRP) is the recommended test in acute inflammatory conditions.
2. Test conducted on EDTA whole blood at 37 °C.
3. ESR readings are auto- corrected with respect to Hematocrit (PCV) values.
GLUCOSE (2.0 hr After 75 gm glucose), PLASMA 73.00 mg/dL 70.00 - 140.00

(Hexokinase)
*175081535* Page 13 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report
TORCH PANEL, IgG & IgM, SERUM

(CMIA, CLIA)
Toxoplasma IgG <0.2 IU/mL <1.60
Toxoplasma IgM <0.10 Index <0.50
Rubella IgG 89.50 IU/mL <5.00
Rubella IgM 0.03 Index <1.20
Cytomegalovirus, IgG 142.50 AU/mL <6.00
Cytomegalovirus, IgM 0.21 Index <1.00
Herpes simplex virus 1+2, IgG <0.500 Index <0.90
Herpes simplex virus 1+2, IgM <0.500 Index <0.90
Interpretation
----------------------------------------------------------------------
| INFECTION | UNITS | NON REACTIVE | EQUIVOCAL | POSITIVE |
|---------------|------------|---------------|------------|------------|
| Toxoplasma IgG| IU/mL | <1.60 | 1.60-<3.00 | >=3.00 |
|---------------|------------|---------------|------------|------------|
| Rubella IgG | IU/mL | <5.00 | 5.00-<10.00| >=10.00 |
|---------------|------------|---------------|------------|------------|
| CMV IgG | AU/mL | <6.00 | NA | >=6.00 |
|---------------|------------|---------------|------------|------------|
| HSV 1+2 IgG | Index | <0.90 | 0.90-<1.10 | >=1.10 |
|---------------|------------|---------------|------------|------------|
| Toxoplasma IgM| Index | <0.50 | 0.50-<0.60 | >=0.60 |
|---------------|------------|---------------|------------|------------|
| Rubella IgM | Index | <1.20 | 1.20-<1.60 | >=1.60 |
|---------------|------------|---------------|------------|------------|
| CMV IgM | Index | <1.00 | NA | >=1.00 |
|---------------|------------|---------------|------------|------------|
| HSV 1+2 IgM | Index | <0.90 | 0.90-<1.10 | >=1.10 |
----------------------------------------------------------------------
TORCH IgG
Note:
1. This assay is used for quantitative detection of specific IgG antibodies to TORCH in serum samples.
2. Positive result indicates past infection with TORCH. Pregnant females with positive TORCH specific
IgG antibodies are considered to be immune and hence risk of transmission of infection to fetus is
*175081535*
Page 14 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report

minimal.
3. Equivocal results should be re-tested in 10-14 days.
4. Negative result indicates person has not been exposed to TORCH in the past. Pregnant females with
negative TORCH specific IgG antibodies are considered at risk of transmission of infection to fetus.
Patients with negative results in suspected disease should be re-tested after 10-14 days. False
negative results can be due to immunosuppression or due to low/undetectable level of IgG antibodies.
5. To differentiate between recent and past infection, Toxoplasma, Rubella & CMV IgG avidity test is
indicated.
6. Demonstration of rising antibody titer (four folds) in acute and convalescent sera taken 2-3 weeks apart
are indicative of TORCH infection.
7. The result should be interpreted in conjunction with clinical finding and other diagnostic tests. The
magnitude of the measured result is not indicative of the amount of antibody present.
TORCH IgM
Note
1. This assay is used for detection of specific IgM antibodies to TORCH in serum samples.
2. Positive result for TORCH IgM indicates possible acute infection with TORCH. False positive reaction
due to rheumatoid factor and persistence of positive IgM (except Herpes Simplex virus) for upto 2 years
is not uncommon.
3. An equivocal result requires repeat testing in 10-14 days.
4. Negative result indicates no serological evidence of infection with TORCH. False negative can be due
to immunosuppression or due to low/undetectable level of IgM antibodies. A suspected diagnosis of
acute TORCH infection should be confirmed by PCR analysis or repeat test after 10-14 days.
5. The diagnosis should not be established on the basis of single test and the results should be
interpreted in conjunction with clinical findings.
6. The magnitude of the measured result is not indicative of the amount of antibody present.
Comments
Perinatal infections account for 2-3% of all congenital anomalies. TORCH which includes Toxoplasma,
Rubella, Cytomegalovirus & Herpes Simplex virus, are some of the most common infections associated with
Congenital anomalies. Most of the TORCH infections cause mild maternal morbidity, but have serious fetal
consequences. Reliable recognition of acute infection is highly important in pregnant women. IgM-positive
result alone does not accurately predict the risk of fetal infection; a positive IgM test should therefore be
considered only as a starting point and a more thorough diagnostic evaluation is necessary to determine
whether there is a risk of fetal infection. Primary CMV infection may result in establishment of persistent or
latent infection. In man the infection is usually asymptomatic. Infections can be acquired through direct contact
with individuals shedding the virus. Once HSV infection occurs, it persists in a latent state in sensory ganglia
*175081535*
Page 15 of 18
.

Lab No. : 175081535 Age : 24 Years
DELHI 110085
Test Report

from where it may re-emerge to cause periodic recurrence of infection induced by many stimuli, which may or
may not result in clinical lesions. Demonstration of Toxoplasma IgG in the serum of person with eye lesion
helps in diagnosing ocular toxoplasmosis while persistent or increasing IgG antibody levels in the infant
compared with the mother and/or positive result of Toxoplasma specific IgM or IgA are diagnostic of Congenital
toxoplasmosis. Demonstration of rising antibody titer (four folds) in acute and convalescent sera taken 2-3
weeks apart are indicative of postnatal Rubella infection and to check response to Rubella vaccination. Single
test results of CMV IgG are useful in screening organ transplant recipients and donors before transplantation
and donors of blood products that are to be administered to premature infants and bone marrow transplant
patients. Positive result of HSV (1+2) IgG indicates past infection with Herpes Simplex virus or administration
of HSV immunoglobulins. Reliable recognition of acute infection is highly important in pregnant women.
IgM-positive result alone does not accurately predict the risk of fetal infection; a positive IgM test should
therefore be considered only as a starting point and a more thorough diagnostic evaluation is necessary to
determine whether there is a risk of fetal infection.
*175081535*
Page 16 of 18
.

Lab No. : 175081535 Age : 24 Years
National Reference laboratory, Block E, Sector National Reference laboratory, Block E, Sector
18, ROHINI 18, Rohini, New Delhi -110085
DELHI 110085
Test Report
CULTURE, URINE
(Conventional culture, Automated-MIC, MALDITOF-MS, KBDD)
Type of Specimen :
Result :- No Aerobic pyogenic organism grown
Dr Ajay Gupta Dr Gurleen Oberoi Dr Himangshu Mazumdar Dr Jatin Munjal

MD, Pathology DM(Hematopathology), MD, Biochemistry MD,Pathology
Technical Director - Hematology & MD,DNB,MNAMS Sr. Consultant Biochemist Consultant Pathologist
Immunology Senior Consultant and Lead- NRL - Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd Hematopathology
NRL - Dr Lal PathLabs Ltd
Dr.Kamal Modi Dr Nimmi Kansal Dr Puneeta Singh Dr Sarita Kumari Lal

MD, Biochemistry MD, Biochemistry Ph.D (Microbiology) MD, Pathology
Consultant Biochemist Technical Director - Clinical Chemistry Principal Research Scientist Consultant Pathologist
NRL - Dr Lal PathLabs Ltd & Biochemical Genetics NRL - Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
Dr Shalabh Malik Dr Sunanda

MD, Microbiology MD, Pathology
Technical Director - Microbiology, Sr. Consultant Pathologist -
Infectious Disease Molecular & Hematology & Immunology
Serology, Clinical Pathology NRL - Dr Lal PathLabs Ltd
*175081535*
Page 17 of 18
.

Lab No. : 175081535 Age : 24 Years
National Reference laboratory, Block E, Sector National Reference laboratory, Block E, Sector
18, ROHINI 18, Rohini, New Delhi -110085
DELHI 110085
Test Report

-------------------------------End of report --------------------------------
AHEEEHAPMKALFOGAKGHMKINKACOEFLFCNKKOCNLCJDCJOPAHEEEHA
BNFFFNBPAOFKFGEOAKJDEDFHAHFHACEGMGIGIOJPMHAONPBNFFFNB
GPFAACFOINFNMACOFGDKIGJOGABFDDJIKFPCBNFBOKKKMLECFGHOL
CJEFPNFLKOMAMGCGEAKHPLPGMPHELDCIKNHOFNMFOMCHFKNODGFCG
NCOHGIFLHNKLHAALCNKDICIMCGHDCJKAOEPIBKPJKEDGHKFPGKPCH
EMNCEMFMEMIFHMCHOJECKKEGBGDBKECNOONECEMFMKAAEMEEBIPKO
AOMCAHFHAFIMMNDMNABPCKLIAHFHAKBEMLNCAKFFOECNAHFHACPHK
FGKPFEFGABGGDAGDHAHAHJPCGGGFBKAFPCECBNFFOBDGGCHFBHDDK
CFJNDIFKGPLLKMLNAMKLOPPDFEJFPNCDKLNKBMMBKNCIBACDIFHOC
PIEGGAFILBGKNJOEJALLAFLDIPLCFHKHPPPNBDHOJNDPKBOAAEHCP
JMKBNJFIBEAODBPNPIFDJEOKPLIFFNLHKFNDBKELLLCOLFGIKJNNL
MNNFNNEHCEIPKGEAELKAOKIHAHFHAFKHNKFGFLNPOLKIAHFHACHPL
APBBBPAPBALONHHCOCEJFJFNBCHCACADMGMIBNNBOLCCCHHCFABAJ
HHHHHHHPHPHHHPHHPPHHHPPHHHPPPPPHPPPPHPPHPHHPHHPPHPHPP
IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.
*175081535*
Page 18 of 18

175081535_eylqkynhkfkbd3ib5uwahrih

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

175081535_eylqkynhkfkbd3ib5uwahrih

Uploaded by

Copyright:

Available Formats

.

Name : Ms. RADHIKA GARG

Test Name Results Units Bio. Ref. Interval

Glucose, Fasting 79.00 mg/dL 70.00 - 100.00

Name : Ms. RADHIKA GARG

COMPLETE BLOOD COUNT;CBC

Hemoglobin 12.30 g/dL 12.00 - 15.00

Name : Ms. RADHIKA GARG

2. Test conducted on EDTA whole blood

Name : Ms. RADHIKA GARG

Test Name Results Units Bio. Ref. Interval

Peak 2 4.10 % <9.60

Hb Adult 86.60 % 83.24 - 90.79

Hb A2 2.70 % 1.50 - 3.50

Others (Non Specific) 6.20 % <10.00

Hemoglobin 12.30 g/dL 12.00 - 15.00

RBC Count 4.31 mill/mm3 3.80 - 4.80

Packed Cell Volume (PCV) 37.20 % 36.00 - 46.00

MCV 86.20 fL 83.00 - 101.00

MCH 28.60 pg 27.00 - 32.00

RDW 14.90 % 11.60 - 14.00

Name : Ms. RADHIKA GARG

Test Name Results Units Bio. Ref. Interval

Name : Ms. RADHIKA GARG

HIV 1 & 2 ANTIBODIES SCREENING TEST, SERUM

HIV 1 / 2 & P 24 COMBO TEST

Name : Ms. RADHIKA GARG

Test Name Results Units Bio. Ref. Interval

Colour Light Yellow Pale yellow

Specific Gravity <=1.005 1.001 - 1.030

pH 8.5 5.0 - 8.0

Proteins Negative Negative

Glucose Negative Negative

Ketones Negative Negative

Bilirubin Negative Negative

Urobilinogen Negative Negative

Leucocyte Esterase Negative Negative

Nitrite Negative Negative

R.B.C. Negative 0.0 - 2.0 RBC/hpf

Pus Cells Negative 0-5 WBC / hpf

Epithelial Cells 0-1 Epi Cells/hpf 0.0 - 5.0 Epi

Crystals None seen None seen

Others None seen None seen

Name : Ms. RADHIKA GARG

Test Name Results Units Bio. Ref. Interval

RPR, SERUM Non Reactive

HEPATITIS B SURFACE ANTIGEN;HBsAg, SERUM Non Reactive Non Reactive

*Specific Antibody Neutralization Assay is performed on all Reactive results.

Name : Ms. RADHIKA GARG

Test Name Results Units Bio. Ref. Interval

Name : Ms. RADHIKA GARG

Test Name Results Units Bio. Ref. Interval

BLOOD GROUP, ABO & RH TYPING

Note: 1. Both forward and reverse grouping performed

T4 FREE & TSH ULTRASENSITIVE

TSH, Ultrasensitive 1.730 µIU/mL 0.550 - 4.780

Reference Ranges for pregnancy

Name : Ms. RADHIKA GARG

Test Name Results Units Bio. Ref. Interval

Name : Ms. RADHIKA GARG

Test Name Results Units Bio. Ref. Interval

HbA1c 5.7 % 4.00 - 5.60

Estimated average glucose (eAG) 117 mg/dL

Name : Ms. RADHIKA GARG